The approved Wegovy schedule starts at 0.25 mg/week for 4 weeks, escalates through 0.5 mg, 1.0 mg, and 1.7 mg, reaching the maintenance dose of 2.4 mg/week at week 17 [3]
"I would do whatever I needed to do to avoid that mirror, because it made me feel so bad." But after losing 80 pounds (and counting), the 35-year-old cardiac tech from Oklahoma can't wait for this year's Thanksgiving Day dinner
However, the risk for thyroid cancer was significantly higher within the first year after GLP-1RA initiation and was amplified in the overall as-treated analysis that censored patients when therapy was discontinued or another medication was added. The research team indicates this could be a sign that GLP-1 users are being screened for thyroid cancer at a higher rate than other diabetes drugs, resulting in a spike in diagnoses in the first year of taking the drug
doi: 10.1371/journal.pone.0045047 323 ZhouMYuanWYangBPeiWMaJFengQ
Antioxidant/oxidant (BAP/dROMs) ratio was calculated to express relative antioxidant capacity
Symptoms of adrenal dysfunction, such as fatigue and brain fog, are discussed, highlighting their overlap with thyroid issues